Bates Shannon M, Middeldorp Saskia, Rodger Marc, James Andra H, Greer Ian
Department of Medicine, McMaster University and Thrombosis and Atherosclerosis Research Institute (TaARI), 1280 Main Street West, HSC 3W11, Hamilton, ON, L8S 4K1, Canada.
Department of Vascular Medicine, University of Amsterdam, Amsterdam, The Netherlands.
J Thromb Thrombolysis. 2016 Jan;41(1):92-128. doi: 10.1007/s11239-015-1309-0.
Venous thromboembolism (VTE), which may manifest as pulmonary embolism (PE) or deep vein thrombosis (DVT), is a serious and potentially fatal condition. Treatment and prevention of obstetric-related VTE is complicated by the need to consider fetal, as well as maternal, wellbeing when making management decisions. Although absolute VTE rates in this population are low, obstetric-associated VTE is an important cause of maternal morbidity and mortality. This manuscript, initiated by the Anticoagulation Forum, provides practical clinical guidance on the prevention and treatment of obstetric-associated VTE based on existing guidelines and consensus expert opinion based on available literature where guidelines are lacking.
静脉血栓栓塞症（VTE）可表现为肺栓塞（PE）或深静脉血栓形成（DVT），是一种严重且可能致命的病症。在做出管理决策时，由于需要同时考虑胎儿和母亲的健康状况，产科相关VTE的治疗和预防变得复杂。尽管该人群中的绝对VTE发生率较低，但产科相关VTE是孕产妇发病和死亡的重要原因。本手稿由抗凝论坛发起，基于现有指南以及在缺乏指南时依据现有文献的专家共识意见，提供了关于产科相关VTE预防和治疗的实用临床指导。
